FDA considers NT$1bn for clinical trials of COVID-19 vaccines

Taiwan's government will formalize plans by the end of July to allocate NT$1 billion (US$33.9 million) to hold clinical trials of COVID-19 vaccine candidates with the goal of developing an effective vaccine by the first quarter of 2021, according to the head of the Food and Drug Administration (FDA).

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)